Interleukin-23 Subunit p19
- Name
- Interleukin-23 Subunit p19
- Accession Number
- DBCAT005547
- Description
Not Available
- Drugs
Drug Drug Description Guselkumab A monoclonal antibody used to treat moderate to severe plaque psoriasis. Tildrakizumab An interleukin-23 antagonist used to treat moderate to severe plaque psoriasis. Risankizumab An interleukin-23 antagonist used to treat plaque psoriasis, psoriatic arthritis, and Crohn's disease in adults. - Drugs & Drug Targets
Drug Target Type Guselkumab Interleukin-23 subunit alpha target Tildrakizumab Interleukin-23 target Tildrakizumab Cytochrome P450 4A11 enzyme Risankizumab Interleukin-23 target